Australia markets closed

Bon Natural Life Limited (BON)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4050-0.0030 (-0.74%)
At close: 04:00PM EDT
0.4050 0.00 (0.00%)
After hours: 04:11PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Bon Natural Life Limited Announces Major Breakthrough in Apple Polyphenol Technology, Set to Boost Fiscal 2024 Sales

    XI’AN, China, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solution providers in the natural, health and personal care industries, today announced that the Company has achieved significant breakthrough in apple polyphenol extraction technology. This development is set to drive considerable growth in BON's apple polyphenol products in the upcoming fiscal year. Apple polyphenol is a mixed natural compound that

  • GlobeNewswire

    Bon Natural Life Limited Announces $45 Million Broccoli Product Order with Beijing Huahai Keyuan

    XI’AN, China, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has entered into a sales distributing contract with Beijing Huahai Keyuan Technology Co. Ltd. (“Huahai”). The contract grants Huahai the priority rights to sell BON’s broccoli products in the Chinese market with a total product value of US$45 million. BON’

  • GlobeNewswire

    BON Announces Advancement in Sulforaphane, Paving the Way for Rapid Development of Broccoli Extract Products

    XI’AN, China, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an achievement in converting glucoraphanin into sulforaphane, an active ingredient in broccoli extract. BON's dedicated R&D team has conducted extensive research, and completed the design of a new compound system, that, when introduced into the human body, integrates enzymes with br